Comparison of clinical features, risk factors and outcome of invasive pulmonary aspergillosis in critically ill COVID-19, influenza and community acquired pneumonia patients
S. Ali (Karachi (Sindh), Pakistan), K. Jabeen (Karachi (Sindh), Pakistan), J. Farooqi (Karachi (Sindh), Pakistan), S. Awan (Karachi (Sindh), Pakistan), M. Irfan (Karachi (Sindh), Pakistan)
Source: International Congress 2022 – Fungal infections and other relevant COVID-19 findings
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ali (Karachi (Sindh), Pakistan), K. Jabeen (Karachi (Sindh), Pakistan), J. Farooqi (Karachi (Sindh), Pakistan), S. Awan (Karachi (Sindh), Pakistan), M. Irfan (Karachi (Sindh), Pakistan). Comparison of clinical features, risk factors and outcome of invasive pulmonary aspergillosis in critically ill COVID-19, influenza and community acquired pneumonia patients. 1884
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|